Apimeds Pharmaceuticals US growth metrics data for the quarter ended Jun 2026. These growth metrics cover 8 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||
| Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) | 5.13% | -497.61% | -3,084.28% | -327.06% | 98.31% | |||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | -91.47% | 52.46% | 16.82% | -25.31% | -1,106.09% | -153.30% | 88.84% | |
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | 5,431.00 | |||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 102,725.00 | 1,648.00 | 3,839.00 | |||||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | 6,416.00 | |||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -16215.00 | 2,000.00 | 4,277.00 |